SCHEMBL10092206

SCHEMBL10092206

c1cc(-c2cc(-n3c4ccccc4c4ccccc43)cc3c2oc2ccccc23)cc(-n2c3ccccc3c3cc(-c4ccc5oc6ccccc6c5c4)ccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
KDM4E B2RXH2 3/20 0.33
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PLA2G10 O15496 1/20 0.33
PRKDC P78527 1/20 0.33
GGPS1 O95749 1/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
RXFP1 Q9HBX9 2/20 0.31
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10092204 0.93 ALOX5 (0.40) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL22672208 0.91 ALOX5 (0.47) ALOX5KDM4EPLA2G2APLA2G4AATM
SCHEMBL10092186 0.91 L3MBTL1 (0.39) ALOX5KDM4EPLA2G2APLA2G4AATM
SCHEMBL5028255 0.91 ALOX5 (0.43) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL22181960 0.90 ALOX5 (0.40) ALOX5KDM4EPLA2G2APLA2G4AATM
SCHEMBL29343738 0.90 L3MBTL1 (0.40) ALOX5KDM4EPLA2G2APLA2G4AATM
SCHEMBL12925769 0.90 L3MBTL1 (0.44) ALOX5KDM4EPLA2G2APLA2G4AATM
SCHEMBL29345127 0.90 KDM4E (0.39) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL12925798 0.89 ALOX5 (0.42) ALOX5KDM4EPLA2G2APLA2G4AATM
SCHEMBL12925854 0.89 KDM4E (0.39) ALOX5KDM4EPLA2G2APLA2G4AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2453496-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2012-05-16 EP disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME AOC2, AOC3, CDYL ALOX5 855/4885KDM4E 367/4885PLA2G2A 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.